Synthesis of CCR5 receptor antagonists

Details Synthesis of CCR5 receptor antagonists Synthesis of CCR5 receptor antagonists

2006-01-05

2010-06-01

Balasubramanian, Venkataraman (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C544S364000, C544S335000

Reexamination Certificate

active

07728135

ABSTRACT:
The present invention is directed to the synthesis of 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine], and intermediates therefor from readily available starting materials by a novel route.

REFERENCES:
patent: 6720325 (2004-04-01), Miller
patent: WO96/26196 (1996-08-01), None
International Search Report for PCT/US2006/000262; mailed Jun. 21, 2006.

Affiliated with

Also associated with

Rating

Synthesis of CCR5 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthesis of CCR5 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis of CCR5 receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4174371